Wang Jian Fei - Net Worth and Insider Trading

Wang Jian Fei Net Worth

The estimated net worth of Wang Jian Fei is at least $936,805 dollars as of 2024-06-21. Wang Jian Fei is the Director of Wuhan Easy Diagnosis Biomedicine Co Ltd and owns about 52,394 shares of Wuhan Easy Diagnosis Biomedicine Co Ltd (SZSE:002932) stock worth over $936,805. Details can be seen in Wang Jian Fei's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Wang Jian Fei has not made any transactions after 2022-02-16 and currently still holds the listed stock(s).

Transaction Summary of Wang Jian Fei

To

Wang Jian Fei Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Wang Jian Fei owns 1 companies in total, including Wuhan Easy Diagnosis Biomedicine Co Ltd (SZSE:002932) .

Click here to see the complete history of Wang Jian Fei’s form 4 insider trades.

Insider Ownership Summary of Wang Jian Fei

Ticker Comapny Transaction Date Type of Owner
SZSE:002932 Wuhan Easy Diagnosis Biomedicine Co Ltd 2022-02-16 Director

Wang Jian Fei Latest Holdings Summary

Wang Jian Fei currently owns a total of 1 stock. Wang Jian Fei owns 52,394 shares of Wuhan Easy Diagnosis Biomedicine Co Ltd (SZSE:002932) as of February 16, 2022, with a value of $936,805.

Latest Holdings of Wang Jian Fei

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SZSE:002932 Wuhan Easy Diagnosis Biomedicine Co Ltd 2022-02-16 52,394 17.88 936,805

Holding Weightings of Wang Jian Fei


Wang Jian Fei Form 4 Trading Tracker

According to the SEC Form 4 filings, Wang Jian Fei has made a total of 3 transactions in Wuhan Easy Diagnosis Biomedicine Co Ltd (SZSE:002932) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Wuhan Easy Diagnosis Biomedicine Co Ltd is the sale of 17,317 shares on February 16, 2022, which brought Wang Jian Fei around $596,622.

Insider Trading History of Wang Jian Fei

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Wang Jian Fei Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Wang Jian Fei Ownership Network

Ownership Network List of Wang Jian Fei

No Data

Ownership Network Relation of Wang Jian Fei

Insider Network Chart

Wang Jian Fei Owned Company Details

What does Wuhan Easy Diagnosis Biomedicine Co Ltd do?

Who are the key executives at Wuhan Easy Diagnosis Biomedicine Co Ltd?

Wang Jian Fei is the Director of Wuhan Easy Diagnosis Biomedicine Co Ltd. Other key executives at Wuhan Easy Diagnosis Biomedicine Co Ltd include and Directors & executives Wang Rui .

Wuhan Easy Diagnosis Biomedicine Co Ltd (SZSE:002932) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Wuhan Easy Diagnosis Biomedicine Co Ltd (SZSE:002932) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Wuhan Easy Diagnosis Biomedicine Co Ltd (SZSE:002932) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Wuhan Easy Diagnosis Biomedicine Co Ltd (SZSE:002932)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Wuhan Easy Diagnosis Biomedicine Co Ltd Insider Transactions

No Available Data

Wang Jian Fei Mailing Address

Above is the net worth, insider trading, and ownership report for Wang Jian Fei. Currently GuruFocus does not have mailing address information for Wang Jian Fei.

Discussions on Wang Jian Fei

No discussions yet.